Muthu Periasamy, Ph.D.
|
Professor Chair, Department of Physiology and Cell Biology Associate Director, Davis Heart & Lung Research Institute
200 Hamilton Hall 1645 Neil Avenue Columbus OH 43210-1218
614-292-2310 (office) 614-292-4888 (fax) periasamy.1@osu.edu |
 |
Education: Ph.D., Biochemistry and Molecular Biology, University of Montpellier, Monpellier-Cedex, France (1976-1980) Postdoctoral Training: Albert Einstein College of Medicine (1980-1982); Harvard Medical School, Boston (1982-1985)
Research Area: My research is focused on cardiovascular disease, in particular understanding events that lead to heart failure. Heart failure is a progressive disease affecting the myocardium, initially causing poor pumping function and eventually resulting in death. The etiology (mechanisms) of heart failure is poorly understood and the available treatment can only prolong survival for short term. There is no real cure for heart failure and only a heart transplant can save the patient.
The heart is a muscular pump and there is a well-defined set of proteins that determine the beat-to-beat function of the heart. These proteins make up the contractile apparatus responsible for generating force (pumping) and sarcoplasmic reticulum (SR) Ca2+ transport proteins that regulate intracellular Ca2+ levels. The release and removal of calcium from the sarcoplasmic reticulum is responsible for activating the heart muscle to contract and relax (heartbeat). Studies show that changes in Ca2+ handling proteins both in expression and activity can be linked to cardiac dysfunction and heart failure.
Although we now know that the expression and activity of several Calcium handling proteins are altered in heart failure, we do not fully comprehend how these alterations lead to the development of heart failure. To test how altered expression or activity of the SR Ca2+ ATPase (SERCA) cause disease we have generated transgenic mouse models with altered SERCA protein levels. Using these genetically altered models we are studying how a decrease or increase in Ca2+ transport affect myocardial biology and function at the molecular, biochemical and physiological levels. We use a variety of techniques, including Genomics, Proteomics and calcium imaging in isolated myocytes. Our long-term goal is to study the role of Calcium homeostasis in cardiac function and disease. This research should also lead to identifying potential therapeutic targets, to delay or even prevent development of Heart Failure.
The current areas of research include:
· The role of SR Calcium ATPase in cardiac function and disease using genetically altered mouse models
· Understanding SERCA pump regulation by Phospholamban and Sarcolipin two small phosphoproteins
· Role of luminal SR proteins in calcium storage and release (Triadin, junctin and Calsequestrin, a Ca2+ storage protein)
· The role of Myosin Isoforms in Smooth muscle
|

|
| Localization of Calsequestrin WT and Mutant CASQ to the SR. Confocal Microscopy images stained for a-Actinin (green) to mark Z-lines and CASQ2(Red) in cardiomyocytes from CASQ2D307H(TG) and WT mice. Merge shows co-localization.(Kalyanasundaram ,et al 2008) |
Current Research Support:
• NIH - RO1 HL-64140-07 (01/01/2004 - 12/31/2008), SR Ca2+ ATPase, a critical determinant of cardiac contractility, PI: Muthu Periasamy, PhD
• NIH/NHLBI-R01 HL 088555 (01/01/2008 - 12/31/2013), Mechanisms regulating SR- Ca2+ ATPase in the Atria, PI: Muthu Periasamy, Ph.D. (Priority Score 124, percentile 2.9%)
• NIH T32 training grant for IBGP Graduate Students, PI: Allan Yates
• AHA - Scientist Development Grant to Yingbi Zhou, MD, PhD, 2007-2010 (National)
• AHA - Postdoctoral fellowship - Mei Chi, MD, PhD, 2006-2008 (Ohio Affiliate)
Publications: • Babu GJ, Bhupathy P, Petrashevskaya NN, Jagatheesan G, Wieczorek D, Schwartz A, Janssen PM, Ziolo MT, Periasamy M. Targeted overexpression of sarcolipin in the mouse heart decreases sarcoplasmic reticulum calcium transport and cardiac contractility. J Biol Chem. 2006 Feb 17; 281(7):3972-9.
• Periasamy M, Kalyanasundaram A. SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve, 2007 Apr; 35(4):430-42. Review. • Dirksen WP, Lacombe VA, Chi M, Kalyanasundaram A, Viatchenko-Karpinski S, Terentyev D, Zhou Z, Vedamoorthyrao S, Li N, Chiamvimonvat N, Carnes CA, Franzini-Armstrong C, Gyorke S, Periasamy M. A mutation in Calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice. Cardiovasc Res, 2007 Jul 1; 75(1):69-78. • Babu GJ, Bhupathy P, Carnes CA, Billman GE, Periasamy M. Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology. J Mol Cell Cardiol, 2007 Aug; 43(2):215-22. • Bhupathy P, Babu GJ, Periasamy M. Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. J Mol Cell Cardiol, 2007 May; 42(5):903-11. Review. • Iyengar S, Haas G, Lamba S, Orsinelli DA, Babu GJ, Ferketich AK, Yamokoski L, Periasamy M, Abraham WT. Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy. J Card Fail, 2007 May; 13(4):304-11. • Talukder MA, Kalyanasundaram A, Zhao X, Zuo L, Bhupathy P, Babu GJ, Cardounel AJ, Periasamy M, Zweier JL. Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction. Am J Physiol Heart Circ Physiol, 2007 Oct; 293(4):H2418-28. • Janssen PM, Periasamy M. Determinants of frequency-dependent contraction and relaxation of mammalian myocardium. J Mol Cell Cardiol, 2007 Nov; 43(5):523-31. • Babu GJ, Bhupathy P, Timofeyev V, Petrashevskaya NN, Reiser PJ, Chiamvimonvat N, Periasamy M. Ablation of sarcolipin enhances sarcoplasmic reticulum calcium transport and atrial contractility. Proc Natl Acad Sci U S A, 2007 Nov 6; 104(45):17867-72. • Periasamy M, Bhupathy P, Babu GJ. Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovasc Res, 2008 Feb 1; 77(2):265-73. • Talukder MA, Kalyanasundaram A, Zuo L, Velayutham M, Nishijima Y, Periasamy M, Zweier JL. Is Reduced SERCA2a Expression Detrimental or Beneficial to Postischemic Cardiac Function and Injury? Evidence from Heterozygous SERCA2a Knockout Mice. Am J Physiol Heart Circ Physiol, 2008 Jan 18; [Epub ahead of print]

Laboratory Members: Poornima Bhupathy, Postdoctoral Researcher (now at Univ of CO) Anu Kalyanasundaram, Graduate Student Naresh Bal, Ph.D., Postdoctoral Researcher Mei Chi, Ph.D., Postdoctoral Researcher Dr. Periasamy Yingbi Zhou, Ph.D., Research Scientist
Subash Chandra Gupta, Ph.D., Postdoctoral Researcher
Collaborators: Paul M.L. Janssen, Ph.D., The Ohio State University Sandor Gyorke, Ph.D., The Ohio State University Litsa Kranias, Ph.D., University of Cincinnati David H MacLennan, Ph.D., University of Toronto Nip Chiamvimonvat, M.D., University of California-Davis
|